A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma

"Phase I Starting Dose Level: 15 mg by mouth on Days 1 - 14 of each 21 day cycle.~Phase II Starting Dose Level: Maximum tolerated dose from Phase I."

Phase I and II: 1000 mg by vein on Days 1, 8, and 15 of Cycle 1 and Day 1 of Cycles 2 - 6.

Phase I and II: 750 mg/m2 vein over about 1 hour on Day 1 of all cycles.

Phase I and II: 50 mg/m2 by vein over about 15 minutes each on Day 1 of all cycles.

Phase I and II: 1.4 mg/m2 by vein on Day 1 of all cycles.

Phase I and II: 100 mg by mouth daily on Days 1 - 5 of each 21 day cycle.